Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in patients with tuberculosis-associated chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. [PDF]
Wu F +14 more
europepmc +1 more source
A Study on the Use of Nebulized Glycopyrronium in Hospitalized Patients With Exacerbations of Obstructive Airway Disease. [PDF]
Khanna A, Tandon A, Narasimhan R L.
europepmc +1 more source
Letter to the Editor Regarding "Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study". [PDF]
Golpe R.
europepmc +1 more source
Fluticasone- vs Budesonide-Based Dual Therapy for COPD.
Feldman WB +6 more
europepmc +1 more source
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies. [PDF]
Bednarczyk A +15 more
europepmc +1 more source
Hyperglycemia impairs microglia responding to retinal vasculopathy via enhanced norepinephrine-ADRB2 signaling. [PDF]
Bu S +9 more
europepmc +1 more source
Asthma: onset at young, persist when grow up. [PDF]
Siu KK, Lin LY, Kwok WC.
europepmc +1 more source
South African Thoracic Society position statement on asthma in children, adolescents and adults. [PDF]
Masekela R +3 more
europepmc +1 more source
Anti-inflammatory reliever therapy for asthma using inhaled budesonide/formoterol as-needed with or without maintenance in South African children (AIR-SA 001): a description of a randomised clinical trial protocol. [PDF]
Hlophe ST +9 more
europepmc +1 more source

